Fenofibrate Improves Cognitive Impairment Induced by High-Fat High-Fructose Diet: A Possible Role of Irisin and Heat Shock Proteins

ACS Chem Neurosci. 2022 Jun 15;13(12):1782-1789. doi: 10.1021/acschemneuro.2c00186. Epub 2022 Jun 2.

Abstract

A high-fat, high-fructose diet (HFFD) impairs cognitive functions and increases susceptibility to neurodegenerative disorders. Irisin and heat shock protein 70 (HSP70) are well known for their role in neuroprotection. The possible neuroprotective effects of fenofibrate on HFFD-induced cognitive dysfunction and the involvement of irisin and HSP70 in these effects were investigated in this study. Rats were divided into normal control, HFFD, dimethylsulfoxide+HFFD, and fenofibrate+HFFD groups. At the end of the experiment, fenofibrate treatment restored hippocampus histological characteristics to almost normal and improved HFFD-induced cognitive deficit. It reduced body weight gain and had hypolipidemic effects by significantly lowering total cholesterol, triglycerides, and low-density lipoprotein cholesterol levels while increasing high-density lipoprotein cholesterol levels. It has antioxidant and anti-inflammatory effects as it significantly reduced the hippocampal malondialdehyde, interleukin-6, and tumor necrosis factor-alpha levels, while significantly increasing the reduced glutathione level. It prevented HFFD-induced hypoxia by significantly lowering hippocampal vascular endothelial growth factor and hypoxia-inducible factor-1 alpha levels. It significantly activated the hippocampal peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1α)/irisin/brain-derived neurotrophic factor pathway. It significantly increased hippocampal HSP70 while decreasing the HSP90 levels. It enhanced synaptic plasticity by significantly upregulating the hippocampal relative GluR1 gene expression. Furthermore, hippocampal irisin levels in the HFFD group were found to be positively correlated with cognitive function, hippocampal HSP70, and relative GluR1 gene expression levels, while negatively correlated with hippocampal HSP90 and HIF1α levels. Therefore, fenofibrate may be used as a potential medication to treat HFFD-induced neurodegenerative disorders.

Keywords: PGC-1α/irisin/BDNF pathway; cognitive impairment; fenofibrate; heat shock proteins; high-fat high-fructose diet; oxidative stress.

MeSH terms

  • Animals
  • Cholesterol / metabolism
  • Cognitive Dysfunction* / drug therapy
  • Cognitive Dysfunction* / etiology
  • Cognitive Dysfunction* / metabolism
  • Diet, High-Fat* / adverse effects
  • Fenofibrate* / pharmacology
  • Fibronectins* / metabolism
  • Fructose* / administration & dosage
  • Fructose* / adverse effects
  • Heat-Shock Proteins* / metabolism
  • Hypoxia / drug therapy
  • Hypoxia / metabolism
  • Rats
  • Vascular Endothelial Growth Factor A

Substances

  • FNDC5 protein, rat
  • Fibronectins
  • Heat-Shock Proteins
  • Vascular Endothelial Growth Factor A
  • Fructose
  • Cholesterol
  • Fenofibrate